Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
78.44
+13.24 (20.31%)
Mar 9, 2026, 3:30 PM EDT - Market open

Dianthus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-162.34-84.97-43.56-28.48-13.11
Depreciation & Amortization
0.430.410.360.15-
Loss (Gain) From Sale of Investments
-6.67-6.17-1.42-0.61-
Stock-Based Compensation
22.7912.892.91.520.06
Change in Accounts Receivable
-0.050.180.750.07-1.01
Change in Accounts Payable
11.288.190.662.284.92
Change in Unearned Revenue
4.571.55-0.060.89-
Change in Other Net Operating Assets
0.93-10.283.5-4.89-0.77
Operating Cash Flow
-129.06-78.18-36.86-29.07-9.9
Capital Expenditures
-0.21-0.11-0.11-0.14-0.03
Investment in Securities
-122.62-286.7120.36-59.68-
Investing Cash Flow
-122.83-286.8120.25-59.82-0.03
Short-Term Debt Issued
--0.38--
Total Debt Issued
--0.38--
Short-Term Debt Repaid
---0.38--
Total Debt Repaid
---0.38--
Issuance of Common Stock
280.49270.290.01--
Other Financing Activities
-0.36-14.67133.57-3.32-0.09
Financing Cash Flow
280.13255.62133.5796.6814.91
Net Cash Flow
28.23-109.37116.977.794.98
Free Cash Flow
-129.27-78.29-36.97-29.21-9.94
Free Cash Flow Margin
-6349.36%-1255.57%-1308.24%-455.18%-673.24%
Free Cash Flow Per Share
-3.35-2.35-7.17-33.41-2.48
Levered Free Cash Flow
-98.24-43.48-22.81-19.31-
Unlevered Free Cash Flow
-98.24-43.48-22.81-19.31-
Change in Working Capital
16.73-0.354.86-1.653.14
Source: S&P Capital IQ. Standard template. Financial Sources.